HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
about
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersThe microRNA cluster miR-183/96/182 contributes to long-term memory in a protein phosphatase 1-dependent manner.Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disordersValproate-induced neurodevelopmental deficits in Xenopus laevis tadpoles.Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder: An Educational Review.Epigenetic mechanisms underlying learning and the inheritance of learned behaviorsThe Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinctionColonic bacterial composition in Parkinson's disease.Impaired Contextual Fear Extinction Learning is Associated with Aberrant Regulation of CHD-Type Chromatin Remodeling Factors.MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction.The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation.Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers.Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia.Drugs, games, and devices for enhancing cognition: implications for work and society.New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders.Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells.Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive MedicineEnhanced Histone Acetylation in the Infralimbic Prefrontal Cortex is Associated with Fear Extinction.Female mimicry by sneaker males has a transcriptomic signature in both the brain and gonad in a sex changing fish.Dnmt3a2: a hub for enhancing cognitive functions.FORMINg a link between PTSD and AD.Mutual inhibition between HDAC9 and miR-17 regulates osteogenesis of human periodontal ligament stem cells in inflammatory conditions.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
P2860
Q27006437-59465410-2FBD-4960-9B11-169954E3228DQ27331540-D4B81EA5-7430-4000-882B-5B9E0C06C958Q28396555-A14D891B-E2E3-414E-939C-EB4192F4B2F2Q30404772-E9627BE5-30E5-4E10-BCC0-B53B9DC02854Q33858861-63E4F27B-F8AC-48DA-BCD0-B4568D07D1E7Q33891691-512B4B7D-F6DA-4BDB-BF1A-398E2E0641F7Q35070968-AE080A61-434F-435A-9743-5E6A43428B67Q35210765-F31E1B35-95AB-4379-BBEA-01F22815F0A9Q35693083-DD971CEE-0719-4564-89CD-5B7E25ECB9E3Q36290178-0ED83961-7C46-4981-9626-FE0B98B532E1Q36915362-AC207771-7393-4521-AA6A-E607655B8B2CQ37650463-19F25D40-0E21-4CC0-BD87-3E378BB40C04Q38260795-0CA1F78F-1C98-462C-A5B0-FBBDA1B60DC1Q38418571-CD15ABFC-8BDB-45D1-BB9F-E4DBF00111F1Q38430438-66E4DB81-5E7B-4FED-B09E-E52DDC3DA780Q38646076-2097F809-E332-4EDC-8B01-3433397C28D6Q38797653-76A49278-9ECD-4806-862D-CFAE0287C58BQ38834930-87C0F5F4-765F-4B63-9359-D419743EE020Q39312328-3CAB0D37-ADB0-4A42-A966-CAECCFFB2BF6Q41365481-A71731E9-C2EF-4709-A87E-D9AD8ED59597Q42226799-C7AADEBC-7F20-41D0-B5EA-03EF435CCCF4Q42504397-3A9BD01D-A34D-47E7-839E-8DFB924E958EQ44877054-CE17979D-CEDC-4CBF-85B2-2B194BC18076Q47616756-2CA68148-8314-407E-AEDC-88097636F229Q48107150-022B4C2F-CA4D-48D8-8C5A-5BA3D1B4930BQ52565514-98621381-E099-46BD-8CC0-D20DF2661314Q53428761-67CFC252-16D4-453F-93EB-9AEED49BA6AF
P2860
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@ast
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@en
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@nl
type
label
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@ast
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@en
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@nl
prefLabel
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@ast
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@en
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@nl
P2860
P356
P1476
HDAC inhibitors as cognitive e ...... ma therapy: where do we stand?
@en
P2093
Nigel Whittle
P2860
P304
P356
10.1042/BST20130233
P50
P577
2014-04-01T00:00:00Z